Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingdu Fang is a traditional Chinese herbal formula used primarily for the treatment of high-risk human papillomavirus (HR-HPV) infections. It consists of multiple herbal components, with at least 27 compounds identified through UPLC-QTOF-MS analysis. The formula exhibits multi-targeted pharmacological effects, including anti-inflammatory, antioxidant, and pro-apoptotic activities. Mechanistically, Qingdu Fang acts by inhibiting the PI3K/AKT signaling pathway, leading to cell cycle arrest and induction of apoptosis in HR-HPV-infected cells. Network pharmacology studies have identified key molecular targets such as TP53, JUN, AKT1, STAT3, TNF, and IL6 that are modulated by this formula. Notably, quercetin is one of its active ingredients with broad polypharmacological properties[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingdu Fang.